Chest Medicine
Guideline: Sleep-related breathing disorders in adults.
28 Jun, 2022 | 11:21h | UTCPartial update of the German S3 Guideline Sleep-Related Breathing Disorders in Adults – Somnologie
RCT: Two-day vs. seven-day course of levofloxacin in acute COPD exacerbation.
28 Jun, 2022 | 11:19h | UTCCommentary: Antibiotics in COPD Exacerbations – 2 days vs 7 days – RebelEM
Review: Primary graft dysfunction after clinical lung transplantation.
28 Jun, 2022 | 10:37h | UTC
[Press Release – not published yet]: RCT: Sanofi-GSK report its vaccine targeted against ancestral and Beta strains had an overall efficacy of 72% against the Omicron variant.
27 Jun, 2022 | 11:52h | UTCPress Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine – Sanofi
Commentaries: Bivalent COVID Vax Gets Phase III Win Against Omicron, Companies Say — Sanofi, GSK boast of 72% efficacy against Omicron variant – MedPage Today (free registration required)
Perspective | What Omicron’s BA.4 and BA.5 variants mean for the pandemic.
27 Jun, 2022 | 11:48h | UTCWhat Omicron’s BA.4 and BA.5 variants mean for the pandemic – Nature
M-A: The role of resistance exercise training for improving cardiorespiratory fitness in healthy older adults.
27 Jun, 2022 | 11:42h | UTC
Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study.
27 Jun, 2022 | 11:29h | UTC
Commentary on Twitter
https://twitter.com/STARSurgUK/status/1539596292812423169
Phase 2a RCT: Vaccine efficacy in adults in a respiratory syncytial virus challenge study.
27 Jun, 2022 | 11:21h | UTCVaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study -New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Challenge Study Shows Efficacy of RSV Vaccine in Healthy Adults – HealthDay
Commentary on Twitter
A human challenge model was used to assess the safety and immunogenicity of an RSV prefusion F protein-based vaccine against RSV infection. The vaccine construct has advanced to further clinical testing.https://t.co/KKfqzCyyGF pic.twitter.com/H7i7F8KLmv
— NEJM (@NEJM) June 22, 2022
Systematic Review: Short‐acting inhaled bronchodilators for cystic fibrosis.
27 Jun, 2022 | 11:15h | UTCShort‐acting inhaled bronchodilators for cystic fibrosis – Cochrane Library
Summary: Short-acting inhaled bronchodilators for cystic fibrosis – Cochrane Library
Cohort Study: COVID-19 trajectories among 57 million adults in England.
24 Jun, 2022 | 11:34h | UTCNews Release: Most comprehensive analysis of COVID-19 data reveals previously unattributed deaths – Health Data Research UK
Commentary from one of the authors on Twitter (thread – click for more)
📣 COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records
Proud to share this work with @johanhilge @SpirosDenaxas @BHFDataScience @HDR_UK + team in @LancetDigitalHhttps://t.co/DY96ClN0c3
🧵
— Chris Tomlinson (@tomlincr) June 9, 2022
Position Paper: Teleconsultation in respiratory medicine.
24 Jun, 2022 | 11:11h | UTC
Review: The physiological basis of pulmonary arterial hypertension.
24 Jun, 2022 | 10:45h | UTCThe physiological basis of pulmonary arterial hypertension – European Respiratory Journal
Study Commentary | How FAST can you spot a pneumothorax? breaking down a surprising result comparing ultrasound and chest radiograph in traumatic pneumothorax.
24 Jun, 2022 | 10:39h | UTCOriginal Study: Not so FAST—Chest ultrasound underdiagnoses traumatic pneumothorax – Journal of Trauma and Acute Care Surgery (link to abstract – $ for full-text)
AHA Scientific Statement: Cardiopulmonary consequences of vaping in adolescents.
23 Jun, 2022 | 13:03h | UTCNews Release: Action needed to reduce e-cigarette use among adolescents to lower lifetime CVD risk – American Heart Association
Ivermectin for COVID-19 Cochrane review update: 11 trials and no evidence of benefit shown.
23 Jun, 2022 | 10:38h | UTCNews Release: Ivermectin for COVID-19 review update: 11 trials and no evidence of benefit shown – Liverpool School of Tropical Medicine
Original Article: Ivermectin for preventing and treating COVID‐19 – Cochrane Library
Summary: Ivermectin for preventing and treating COVID-19 – Cochrane Library
Systematic Review: SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19.
23 Jun, 2022 | 10:37h | UTCSARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19 – Cochrane Library
ASA and APSF statement on perioperative testing for the COVID-19 virus.
22 Jun, 2022 | 12:19h | UTCCommentary: ASA, APST Update Perioperative SARS-CoV-2 Testing Recommendations – HealthDay
Related:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
BJS commission on surgery and perioperative care post-COVID-19.
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
Review: Sex differences in sequelae from COVID-19 infection and in long COVID syndrome.
22 Jun, 2022 | 12:06h | UTCCommentary: Women more likely to have long COVID, different symptom profile – CIDRAP
RCT: Efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes.
22 Jun, 2022 | 11:16h | UTCAuthor Interview: Efficacy and Safety of Varenicline in Patients With Type 2 Diabetes – JAMA
Commentary on Twitter
This randomized clinical trial (CoEHAR) found the use of varenicline in smoking cessation programs for patients with diabetes resulted in prolonged abstinence. @CoeharUnict @RiccardoPolosa https://t.co/Sd57LMcsbJ
— JAMA Network Open (@JAMANetworkOpen) June 21, 2022
RCT: High-flow nasal cannula vs. conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia.
22 Jun, 2022 | 11:09h | UTC
Randomized cross-over study: closed-loop oxygen control improves oxygen therapy in acute hypoxemic respiratory failure patients under high flow nasal oxygen.
22 Jun, 2022 | 11:08h | UTC
RCT: Low-dose methylprednisolone does not improve outcomes in critically ill patients with severe community-acquired pneumonia.
21 Jun, 2022 | 11:04h | UTC
How common is long COVID? Why studies give different answers.
21 Jun, 2022 | 11:03h | UTCHow common is long COVID? Why studies give different answers – Nature
WHO Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines.
20 Jun, 2022 | 10:42h | UTCSee also: Interim statement on the composition of current COVID-19 vaccines – World Health Organization
Commentary on Twitter (thread – click for more)
Current #COVID19 vaccines provide high levels of protection against severe disease and death from all variants. They should continue to be used.
🆕 interim statement:https://t.co/bVzzx1HnG2 pic.twitter.com/CJlAJqFr3C
— World Health Organization (WHO) (@WHO) June 17, 2022
Consensus Study: A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research.
20 Jun, 2022 | 10:31h | UTCNews Release: Key outcomes of Long COVID identified in international consensus study – King’s College London
Invited Commentary: Post-COVID-19 condition in children: a COS is urgently needed – The Lancet Respiratory Medicine
Commentary on Twitter
NEW POSITION PAPER—A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research
From Daniel Munblit & co https://t.co/zAxQ1ww6bT pic.twitter.com/WIitohP3Xo
— The Lancet Respiratory Medicine (@LancetRespirMed) June 15, 2022